The effects of normalizing hyperhomocysteinemia on clinical and operative outcomes in patients with critical limb ischemia.
Waters, Peadar S Fennessey, Paul J Hynes, Niamh Heneghan, Helen M Tawfick, Wael Sultan, Sherif
Waters, Peadar S
Fennessey, Paul J
Hynes, Niamh
Heneghan, Helen M
Tawfick, Wael
Sultan, Sherif
Advisors
Editors
Other Contributors
Date
2012-12
Date Submitted
Keywords
Other Subjects
Subject Mesh
Aged
Aged, 80 and over
Amputation
Biological Markers
Chi-Square Distribution
Critical Illness
Disease-Free Survival
Drug Therapy, Combination
Endovascular Procedures
Female
Folic Acid
Hemodynamics
Homocysteine
Humans
Hyperhomocysteinemia
Ischemia
Kaplan-Meier Estimate
Limb Salvage
Logistic Models
Lower Extremity
Male
Middle Aged
Multivariate Analysis
Odds Ratio
Risk Factors
Time Factors
Treatment Outcome
Vascular Patency
Vitamin B 12
Vitamin B Complex
Aged, 80 and over
Amputation
Biological Markers
Chi-Square Distribution
Critical Illness
Disease-Free Survival
Drug Therapy, Combination
Endovascular Procedures
Female
Folic Acid
Hemodynamics
Homocysteine
Humans
Hyperhomocysteinemia
Ischemia
Kaplan-Meier Estimate
Limb Salvage
Logistic Models
Lower Extremity
Male
Middle Aged
Multivariate Analysis
Odds Ratio
Risk Factors
Time Factors
Treatment Outcome
Vascular Patency
Vitamin B 12
Vitamin B Complex
Planned Date
Start Date
Collaborators
Principal Investigators
Alternative Titles
Abstract
To assess the outcome of patients with medically treated hyperhomocysteinemia (HHC) requiring intervention for critical limb ischemia (CLI).
Language
en
ISSN
1545-1550
eISSN
ISBN
DOI
10.1583/JEVT-12-3949MR.1
PMID
23210882